UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 24, 2007
COMPUMED, INC. |
(Exact name of registrant as specified in its charter) |
DELAWARE |
| 000-14210 |
| 95-2860434 |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
5777 West Century Blvd., Suite 1285, Los Angeles, CA |
| 90045 |
(Address of principal executive offices) |
| (Zip Code) |
Registrant's telephone number, including area code: |
| (310) 258-5000 |
|
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS.
On January 24, 2008, CompuMed, Inc. distributed a newsletter talking about its new product developments, market trends and company-related news. A copy of the newsletter is attached herein as Exhibit 99.1 to this Current Report on Form 8-K.
EXHIBIT NUMBER |
| DESCRIPTION |
|
|
|
| Newsletter for Customers and Investors |